NEW YORK, Nov. 21 (GenomeWeb News) - Solexa's shares were down 12.3 percent, or $1.09, at $7.81 in mid-afternoon trading today despite news that the company plans to raise around $61 million in a private stock placement.
Registering provides access to this and other free content.
Already have an account?Login Now.
Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.
The New York Times reports that a number of companies and research institutes are pursuing gene therapies.
Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.
In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.